SUBSCRIBE
SUBSCRIBE

Nuvig Therapeutics, Inc.

NEWS
Business
BioSpace Movers & Shakers: Arvinas, Nuvig, Cambridge Isotope and More
This week’s Movers & Shakers include Arvinas, Inspire and Cambridge Isotope Laboratories all announcing new VP roles, and several others tap new C-suite executives.
August 18, 2022
 · 
4 min read
 · 
Alex Keown
IN THE PRESS
Press Releases
Nuvig Therapeutics Announces $161 Million Series B Financing and Progression to Phase 2 Development with Novel, Second-Generation Immunomodulator
December 5, 2024
 · 
4 min read
Biotech Bay
Nuvig Initiates Clinical Development of Next-Generation Immune Modulator NVG-2089
February 12, 2024
 · 
2 min read
Business
Nuvig Therapeutics Appoints Dr. Alan Glicklich Chief Medical Officer
October 4, 2023
 · 
2 min read
Business
Nuvig Therapeutics Appoints Julie Smith Chief Executive Officer
January 4, 2023
 · 
2 min read
Business
Nuvig Therapeutics Expands Leadership Team with the Appointment of Dr. Joanne Quan as Chief Medical Officer
August 15, 2022
 · 
2 min read
JOBS